期刊文献+

^(125)I粒子永久性植入治疗前列腺癌42例临床分析 被引量:1

Permanent transrectal ^(125)I seeds implantation for analysis of 42 cases prostate cancer
下载PDF
导出
摘要 目的探讨125I放射粒子植入联合手术去势治疗局部晚期前列腺癌的临床效果。方法晚期前列腺癌患者82例,治疗组42例,采用经直肠B超引导下经直肠植入125I放射粒子并同时行双侧睾丸切除治疗。对照组40例施行双侧睾丸切除术。82例患者术后同时服用比卡鲁胺内分泌化疗药物。结果所有患者手术过程顺利,术后随访24~48个月,中位随访时间36.5个月。治疗组平均植入粒子(38±15)粒。无因经直肠穿刺引起的严重并发症。1例术后16个月发生骨转移,有2例在术后平均18.6个月出现PSA生化复发,累计PSA无进展患者生存率为92.8%。对照组中1例于术后23个月死亡,3例在术后14个月发生骨转移,有5例在术后平均15.8个月出现PSA生化复发,累计PSA无进展患者生存率为77.5%。结论对于局部晚期前列腺癌。 Objective To study the clinical efficacy of 125I brachytherapy combined with surgical castration for treating local advanced prostate cancer.Methods A total of 82 prostate cancer patients were recruited.In treatment group,42 patients with advanced prostate cancer underwent 125I transrectal brachytherapy guided by rectal ultrasound B and orchiectomy at the same time.40 cases of control group were performed orchiectomy.Hormonal therapy with Bicalutamide was performed in all patients after operation.Results All procedures were completed smoothly.Follow up ranged from 24~48months,with the median of 36.5 months.In treatment group,the average were(38±15) particles.No severe complication appeared through per-rectum 125I seeds long term implantation.One case was diagnosed with bone metastasis 16 months after the surgery.2 cases had biochemical progression an average of 18.6 months post-operation.Cumulative PSA progression free survival rate was 92.8%.In control group,1 case died in 23 months post-operation.3 case was diagnosed with bone metastasis 14 months after the surgery.5 cases had biochemical progression an average of 15.8 months post-operation.Cumulative PSA progression free survival rate was77.5%.Conclusion The 125I transrectal brachytherapy combined with surgical castration is an effective and safe treatment for locally advanced prostate cancer.
出处 《四川医学》 CAS 2011年第4期458-460,共3页 Sichuan Medical Journal
基金 四川省卫生厅科研课题基金资助(编号:070202)
关键词 经直肠植入125I粒子 前列腺癌 内分泌治疗 transrectal 125 I seeds implantation prostate cancer hormone therapy
  • 相关文献

参考文献7

  • 1Whitmore WF Jr, Hilaris B, Grabstald H. Retropubic implantation of iodine 125 in the treatment of prostatic cancer [ J ]. J Urol, 1972,108:918 -920.
  • 2Merrick GS, Butler WM, Dorsey AT, et al. Rectal function following prostate brachytherapy [ J ]. Int J Radiat Oncol Biol Phys, 2000, 48 (3) : 667 - 674.
  • 3Morris WJ, Keyes M, Palma D, et al. Population-based study of biochemical and survival outcomes after permanent ^125 brachytherapy for low-and intermediate-risk prostate cancer[ J ]. J Urol,2009, 73 (4) : 860 - 865.
  • 4Sharkey J, Cantor A, Solc Z,et al. Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: A 12-year experience from a single group practice [ J ]. Brachytherapy, 2005, 4(1) : 34 -44.
  • 5周云峰,马胜利.前列腺癌的放射治疗进展[J].临床外科杂志,2004,12(2):76-78. 被引量:1
  • 6郭道宁,漆家高,王东,王鸿智,邹晓攀,付光明,辛宇鹏.经直肠超声引导经直肠植入术及其在前列腺癌^(125)I粒子植入中的应用[J].中国超声医学杂志,2009,25(10):980-982. 被引量:11
  • 7王俊杰,张福君.放射性粒子种植治疗前列腺癌[M].第2版.北京:北京大学医学出版社,2007,228-308.

二级参考文献9

  • 1Nag S, Beyer D, Friedland J, et al. American brachytherapy society recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radfat Onco/ Bios Phys, 1999,44:789-799.
  • 2Merriek GS, Butler WM,Dorsey AT, et al. Rectal function following prostate brachytherapy. Int J Radiat OncoI Biol Phys, 2000,48 (3) :667-674.
  • 3王俊杰,张福君.放射性粒子种植治疗前列腺癌.2版.北京:北京大学医学出版社,2007:228-308.
  • 4Hara R,Jo Y,Fujii T,et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology,2008,71(2) : 191-195.
  • 5Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg,2005,75:48-50.
  • 6Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol, 2001,166 (1) :86-91.
  • 7Pollack A, Horwitz EM, Movsas B, et al. Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment. Urol Clin North Am,2003,30:337-349.
  • 8Gillin MT,Dunning BF, Lawton CA, et al. Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. Brachytherapy, 2006,5 (3) : 152- 156.
  • 9Lagerburg V, Moerland MA, Lagendijik J J, et al. Measurement of prosate rotation during insertion of needles for brachytherapy. Radiother Oncol,2005,77(3) :318-323.

共引文献10

同被引文献12

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部